home / stock / crmd / crmd quote
Last: | $11.72 |
---|---|
Change Percent: | 31.69% |
Open: | $9.76 |
Close: | $11.72 |
High: | $12.78 |
Low: | $9.2517 |
Volume: | 4,411,468 |
Last Trade Date Time: | 02/02/2021 04:57:37 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$11.72 | $9.76 | $11.72 | $12.78 | $9.2517 | 4,411,468 | 02-02-2021 |
$8.9 | $9 | $8.9 | $9.68 | $8.5 | 1,444,447 | 02-01-2021 |
$8.75 | $8.75 | $8.75 | $9.04 | $8.6205 | 438,976 | 01-29-2021 |
$8.74 | $8.85 | $8.74 | $9.05 | $8.65 | 457,758 | 01-28-2021 |
$8.76 | $8.7 | $8.76 | $9.0878 | $8.5853 | 476,408 | 01-27-2021 |
$8.9 | $8.6 | $8.9 | $9.2062 | $8.54 | 647,807 | 01-26-2021 |
$8.51 | $8.75 | $8.51 | $8.84 | $8.385 | 598,661 | 01-25-2021 |
$8.64 | $8.52 | $8.64 | $8.67 | $8.39 | 636,529 | 01-22-2021 |
$8.63 | $8.86 | $8.63 | $8.9 | $8.6 | 417,728 | 01-21-2021 |
$8.84 | $9 | $8.84 | $9 | $8.59 | 380,835 | 01-20-2021 |
$8.99 | $8.92 | $8.99 | $9 | $8.65 | 358,635 | 01-19-2021 |
$8.84 | $8.79 | $8.84 | $9.09 | $8.74 | 282,302 | 01-18-2021 |
$8.84 | $8.79 | $8.84 | $9.09 | $8.74 | 282,210 | 01-15-2021 |
$8.9 | $8.88 | $8.9 | $9.08 | $8.81 | 579,793 | 01-14-2021 |
$8.74 | $8.87 | $8.74 | $8.9 | $8.58 | 188,659 | 01-13-2021 |
$8.75 | $8.32 | $8.75 | $8.77 | $8.29 | 342,319 | 01-12-2021 |
$8.32 | $8.79 | $8.32 | $8.85 | $8.17 | 544,995 | 01-11-2021 |
$8.78 | $8.18 | $8.78 | $8.84 | $8.12 | 1,202,612 | 01-08-2021 |
$8.14 | $7.92 | $8.14 | $8.22 | $7.92 | 211,245 | 01-07-2021 |
$7.94 | $7.77 | $7.94 | $8.05 | $7.6 | 286,479 | 01-06-2021 |
News, Short Squeeze, Breakout and More Instantly...
BERKELEY HEIGHTS, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that the U.S. Food and Drug Administration (FDA) has...
2024-06-07 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BERKELEY HEIGHTS, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that the Center for Medicare & Medicaid Services...